[Federal Register Volume 59, Number 137 (Tuesday, July 19, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-17475]


[[Page Unknown]]

[Federal Register: July 19, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

 

Advisory Committee Meeting; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
amendment to the notice of a meeting of the Antiviral Drugs Advisory 
Committee. This meeting was announced in the Federal Register of June 
24, 1994 (59 FR 32699 at 32700). The amendment is being made to reflect 
a change in the date of the meeting from a 1-day to a 2-day meeting and 
a change in the meeting room locations, and to announce a closed 
portion of the meeting, which is now scheduled for the second day. The 
open committee discussion remains the same, except for the date the 
discussions will be held. This amendment will be announced at the 
beginning of the open portion of the meeting.

FOR FURTHER INFORMATION CONTACT: Lee L. Zwanziger or Valerie Mealy, 
Center for Drug Evaluation and Research (HFD-9), Food and Drug 
Administration, 5600 Fishers Lane, Rockville MD 20857 301-443-4695.

SUPPLEMENTARY INFORMATION: In the Federal Register of June 24, 1994, 
FDA announced that a meeting of the Antiviral Drugs Advisory Committee 
would be held on June 29, 1994. On page 32700, in the first column, the 
``Date, time, and place'' and ``Type of meeting and contact person'' 
portions of this meeting are amended, and because the committee will 
now have a closed portion on July 29, 1994, a ``Closed committee 
deliberations'' portion is added to read as follows:
    Date, time, and place. July 28, 1994, 8 a.m., Parklawn Bldg., 
Conference rms. D and E, and July 29, 1994, 8:30 a.m., Parklawn Bldg., 
Conference rms. G, H, I, and J, 5600 Fishers Lane, Rockville, MD.
    Type of meeting and contact person. Open committee discussion, July 
28, 1994, 8 a.m. to 11 a.m.; open public hearing, 11 a.m. to 12 m., 
unless public participation does not last that long; open committee 
discussion, 12 m. to 5 p.m.; closed committee deliberations, July 29, 
1994, 8:30 a.m. to 12 m.; Lee L. Zwanziger or Valerie Mealy, Center for 
Drug Evaluation and Research (HFD-9), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857, 301-443-4695.
    Closed committee deliberations. On July 29, 1994, the committee 
will discuss trade secret and/or confidential commercial information 
relevant to pending NDA's. This portion of the meeting will be closed 
to permit discussion of this information (5 U.S.C. 552b(c)(4)).

    Dated: July 13, 1994.
 Linda A. Suydam,
 Interim Deputy Commissioner for Operations.
[FR Doc. 94-17475 Filed 7-18-94; 8:45 am]
BILLING CODE 4160-01-F